Literature DB >> 24622396

Respiratory syncytial virus disease in preterm infants in the U.S. born at 32-35 weeks gestation not receiving immunoprophylaxis.

Christopher S Ambrose1, Evan J Anderson, Eric A F Simões, Xionghua Wu, Hanaa Elhefni, C Lucy Park, Frangiscos Sifakis, Jessie R Groothuis.   

Abstract

BACKGROUND: The Respiratory Syncytial Virus (RSV) Respiratory Events Among Preterm Infants Outcomes and Risk Tracking (REPORT) study evaluated RSV disease burden in U.S. preterm infants 32-35 weeks gestational age (wGA) not receiving RSV prophylaxis.
METHODS: Preterm infants <6 months of age as of November 1st were followed prospectively at 188 clinics from September to May 2009-2010 or 2010-2011. Nasal and pharyngeal swabs were collected for medically attended acute respiratory illnesses (MAARI) and tested for RSV by qRT-polymerase chain reaction. Risk factors were assessed using multivariate Cox proportional hazard model adjusted for seasonality.
RESULTS: Of 1642 evaluable infants, 287 experienced RSV MAARI. Rates of RSV-related MAARI, outpatient lower respiratory tract illness, emergency department visits and hospitalization (RSVH) during November to March were 25.4, 13.7, 5.9 and 4.9 per 100 infant-seasons, respectively. Preschool-aged, nonmultiple-birth siblings and daycare attendance were consistently associated with increased risk of RSV. RSVH rates were highest in infants 32-34 and 35 wGA who were <6 months of age during November to March with daycare attendance or nonmultiple-birth, preschool-aged siblings (8.9 and 9.3 per 100 infant-seasons, respectively, versus 3.5 for all other infants, P<0.001). Chronologic age <3 months was associated with a higher RSVH rate for infants 35 wGA but not for infants 32-34 wGA.
CONCLUSIONS: In US preterm infants who were 32-35 wGA, <6 months on November 1st and not receiving RSV prophylaxis, the burden of RSV MAARI was 25 per 100 infant-seasons. The highest RSVH rates occurred among those with daycare attendance or nonmultiple-birth, preschool-aged siblings while they were <6 months of age during the RSV season.

Entities:  

Mesh:

Year:  2014        PMID: 24622396      PMCID: PMC4025592          DOI: 10.1097/INF.0000000000000219

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  40 in total

Review 1.  Environmental and demographic risk factors for respiratory syncytial virus lower respiratory tract disease.

Authors:  Eric A F Simoes
Journal:  J Pediatr       Date:  2003-11       Impact factor: 4.406

2.  Severe respiratory syncytial virus infection among otherwise healthy prematurely born infants: What are we trying to prevent?

Authors:  B Law; N Macdonald; J Langley; I Mitchell; D Stephens; E Wang; J Robinson; F Boucher; J McDonald; S Dobson
Journal:  Paediatr Child Health       Date:  1998-11       Impact factor: 2.253

3.  Hospital admission of high risk infants for respiratory syncytial virus infection: implications for palivizumab prophylaxis.

Authors:  T Heikkinen; H Valkonen; L Lehtonen; R Vainionpää; O Ruuskanen
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2005-01       Impact factor: 5.747

4.  Growth rate of lung function in healthy preterm infants.

Authors:  Luciana Friedrich; Paulo M C Pitrez; Renato T Stein; Marcelo Goldani; Robert Tepper; Marcus H Jones
Journal:  Am J Respir Crit Care Med       Date:  2007-09-20       Impact factor: 21.405

5.  Comparative costs of hospitalisation among infants at high risk for respiratory syncytial virus lower respiratory tract infection during the first year of life.

Authors:  Michael L Forbes; Caroline B Hall; Anne Jackson; Anthony S Masaquel; Parthiv J Mahadevia
Journal:  J Med Econ       Date:  2010-03       Impact factor: 2.448

6.  Hospitalization rates for respiratory syncytial virus infection in premature infants born during two consecutive seasons.

Authors:  X Carbonell-Estrany; J Quero
Journal:  Pediatr Infect Dis J       Date:  2001-09       Impact factor: 2.129

7.  Incidence and risk factors of respiratory syncytial virus-related hospitalizations in premature infants in Germany.

Authors:  Johannes G Liese; Eva Grill; Birgit Fischer; Irmgard Roeckl-Wiedmann; David Carr; Bernd H Belohradsky
Journal:  Eur J Pediatr       Date:  2003-03-01       Impact factor: 3.183

8.  Variation in timing of respiratory syncytial virus outbreaks: lessons from national surveillance.

Authors:  Catherine A Panozzo; Ashley L Fowlkes; Larry J Anderson
Journal:  Pediatr Infect Dis J       Date:  2007-11       Impact factor: 2.129

9.  Economic impact of respiratory syncytial virus-related illness in the US: an analysis of national databases.

Authors:  L Clark Paramore; Vincent Ciuryla; Gabrielle Ciesla; Larry Liu
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

10.  The Pediatric Investigators Collaborative Network on Infections in Canada study of predictors of hospitalization for respiratory syncytial virus infection for infants born at 33 through 35 completed weeks of gestation.

Authors:  Barbara J Law; Joanne M Langley; Upton Allen; Bosco Paes; David S C Lee; Ian Mitchell; John Sampalis; Hervé Walti; Joan Robinson; Karel O'Brien; Carina Majaesic; Georges Caouette; Lyne Frenette; Nicole Le Saux; Brian Simmons; Sharon Moisiuk; Koravanagattu Sankaran; Cecil Ojah; Avash J Singh; Marc H Lebel; Godfrey S Bacheyie; Heather Onyett; Andrea Michaliszyn; Patricia Manzi; Diana Parison
Journal:  Pediatr Infect Dis J       Date:  2004-09       Impact factor: 2.129

View more
  29 in total

1.  Preventing hospitalizations for respiratory syncytial virus infection.

Authors:  Joan L Robinson; Nicole Le Saux
Journal:  Paediatr Child Health       Date:  2015 Aug-Sep       Impact factor: 2.253

2.  RSV infection among children born moderately preterm in a community-based cohort.

Authors:  Rolof G P Gijtenbeek; Jorien M Kerstjens; Sijmen A Reijneveld; Eric J Duiverman; Arend F Bos; Elianne J L E Vrijlandt
Journal:  Eur J Pediatr       Date:  2014-09-06       Impact factor: 3.183

3.  Efficacy of palivizumab prophylaxis on the frequency of RSV-associated lower respiratory tract infections in preterm infants: determination of the ideal target population for prophylaxis.

Authors:  M Cetinkaya; T K Oral; S Karatekin; B Cebeci; A Babayigit; Y Yesil
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-04-08       Impact factor: 3.267

4.  Long-Term Burden and Respiratory Effects of Respiratory Syncytial Virus Hospitalization in Preterm Infants-The SPRING Study.

Authors:  Xavier Carbonell-Estrany; Eduardo G Pérez-Yarza; Laura Sanchez García; Juana M Guzmán Cabañas; Elena Villarrubia Bòria; Belén Bernardo Atienza
Journal:  PLoS One       Date:  2015-05-08       Impact factor: 3.240

5.  The Burden of Severe Respiratory Syncytial Virus Disease Among Children Younger than 1 Year in Central and Eastern Europe.

Authors:  Olivier Van de Steen; Farzaneh Miri; Marta Gunjaca; Vanesa Klepac; Baerbel Gross; Gerard Notario; Colleen M Wegzyn
Journal:  Infect Dis Ther       Date:  2016-05-12

6.  Insurance Status and the Risk of Severe Respiratory Syncytial Virus Disease in United States Preterm Infants Born at 32-35 Weeks Gestational Age.

Authors:  Jeremy A Franklin; Evan J Anderson; Xionghua Wu; Christopher S Ambrose; Eric A F Simões
Journal:  Open Forum Infect Dis       Date:  2016-07-29       Impact factor: 3.835

7.  Evaluation of recent New Vaccine Surveillance Network data regarding respiratory syncytial virus hospitalization rates in US preterm infants.

Authors:  John P DeVincenzo; Christopher S Ambrose; Doris Makari; Leonard B Weiner
Journal:  Hum Vaccin Immunother       Date:  2016-02-18       Impact factor: 3.452

8.  Modeling the Potential Impact of the 2014 American Academy of Pediatrics Respiratory Syncytial Virus Prophylaxis Guidance on Preterm Infant RSV Outcomes.

Authors:  Kimmie K McLaurin; Archana Chatterjee; Doris Makari
Journal:  Infect Dis Ther       Date:  2015-10-26

Review 9.  Respiratory Syncytial Virus Hospitalizations in Healthy Preterm Infants: Systematic Review.

Authors:  Josephine Mauskopf; Andrea V Margulis; Miny Samuel; Kathleen N Lohr
Journal:  Pediatr Infect Dis J       Date:  2016-07       Impact factor: 2.129

10.  Predictors of RSV LRTI Hospitalization in Infants Born at 33 to 35 Weeks Gestational Age: A Large Multinational Study (PONI).

Authors:  Zbyněk Straňák; Elie Saliba; Paraskevi Kosma; Klara Posfay-Barbe; Khalid Yunis; Teresa Farstad; Kristina Unnebrink; Jean van Wyk; Colleen Wegzyn; Gerard Notario; Stefanie Kalus; Fiona J Campbell
Journal:  PLoS One       Date:  2016-06-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.